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THE PROBLEM OF IMMUNITY IN TUBERCULOSIS.1 
By Edward R. Baldwin, M.D., 
or 8ASIAN AC LAKE, NEW TO SUL. 
It is my purpose to take a brief retrospect of past achievements 
in attempts artificially to protect against tuberculosis, and then to 
indicate what seems to me the special problems for the future. It 
must be confessed that much discouragement has resulted from the 
numerous experiments on animals in this direction during the past 
two decades. This problem has engaged the thought and labor of 
the foremost workers in immunity research, and it will continue to 
do so with the enthusiastic hope inspired by every new discovery, 
however little it may contribute to the ultimate object. 
A review of the achievements already attained, with due credit to 
the authors for priority, is peculiarly difficult, and also impossible 
in the limits of this address. The difficulties are real because of the 
simultaneous experimentation in different laboratories and countries, 
which have independently followed similar lines impelled by the 
same ideas. The most important example of this common motif is 
the principle of immunization with bacteria of attenuated virulence, 
formulated by the immortal Pasteur and applied to tuberculosis as 
soon as the illustrious Koch made it possible by the discovery of the 
bacillus. It is noteworthy that this principle holds at present the 
leading place in the hope for success in the future, and it is natural 
that these experiments should have begun in France (Daremberg, 
Grancher and Ledoux-Lebard, Martin, Hericourt and Richet, and 
Courmont and Dor). The immediate results were discouraging; too 
little was known of the mechanism of immunity to make use of the 
crude methods then employed as a basis for thorough experimenta¬ 
tion; and the discovery of tuberculin and antitoxins for other diseases 
directed attention to these fields of greater promise. 
As it is not generally known that Americans engaged in the 
earlier experimentation with a considerable degree of success, it is 
appropriate that they should receive mention here. As early as 
1S89 Dixon made some preliminary experiments with attenuated 
bacilli, and Trudeau, working under exceptionally difficult con¬ 
ditions, produced a relatively strong immunity with cultures of 
avian tubercle bacilli (IS92), and later with attenuated human 
cultures. The late Emil de Schweinitz, in 1894, had more marked 
success on guinea-pigs immunized with the same attenuated cul¬ 
tures employed in Trudeau’s experiments. This period was also 
one of diligent but unsuccessful search for antitoxic immunity by 
means of divers extracts and products of the tubercle bacillus. 
The soluble extracts of tubercle bacilli having failed to immunize 
1 Read at the International Congress on Tuberculosis, Washington, D.C., October 1,1908. 
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animals, Koch introduced the emulsions or new tuberculins, “T. R.” 
and “B. E./* which were in some degree protective against infection. 
Experiments with pscudotubercle bacilli and mammalian types, 
supposedly altered by passage through reptilians, also promised 
fruitful results, but they have not fulfilled this hope up to the 
present time. 
The discovery by Theobald Smith, in 1895, of differences in form 
and virulence between bacilli from bovine and human sources, was 
another valuable contribution destined to influence the course of • 
immunity experimentation on cattle. Pearson and Gilliland in 
America were among the first to attain a high degree of immunity 
in cattle by the use of the human type of bacilli, following up their 
first work by an extensive series of practical tests. 
During the past decade many workers have turned to the study of 
immunity against tuberculosis in cattle. Von Behring and Koch 
with their associates have introduced methods of immunization 
for cattle, the basis of which was the intravenous inoculation of liv¬ 
ing human cultures. The “bovovaccin” of von Behring consisted 
of dried human cultures designed to be twice inoculated within an 
interval of three months. The “tauruman” of Koch and Schutz 
was an emulsion of more virulent human type for a single protective 
inoculation. Coincidently, Pearson and Gilliland succeeded equally 
well with successive inoculations during shorter intervals. Besides 
these methods von Baumgarten employed subcutaneous inoculations 
with good results, Calmette and Gufcrin used the gastro-intestinal 
route by feeding the protective virus, and Heymanns enclosed viru¬ 
lent bacilli in capsules which were introduced subcutaneously for 
immunization without resulting danger of infection. Klimmer, of 
Dresden, claims excellent results from the subcutaneous injection of 
a virulent and modified human bacilli supposed to be passed through 
lizards. 
The world-wide interest created by von Behring’s announcement, 
in 1902, of a practicable method of immunizing calves, led to the hope 
that this aspect of the problem had been solved. An enduring im¬ 
munity for cattle with no danger associated with it was an alluring 
prospect, and extensive experiments were at once undertaken. The 
outcome of these has been less satisfactory than was hoped for. A 
high degree of resistance can be conferred by various methods of 
inoculation with human and attenuated bovine bacilli for a period 
varying from six months to two years. Unfortunately, exposure to 
natural infection or to inoculation with bovine virus after this 
period has resulted disastrously. Some of the animals completely 
lose their immunity and others retain but little of it. The situation 
is, therefore, at present not encouraging for the establishment of a 
long-continued immunity by any method, either in cattle or men. 
Moreover, the use of living virulent bacilli as a bovine vaccine, 
either intravenously or subcutaneously, cannot be regarded as safe, 
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since they have been discovered in the subcutaneous abscesses and 
milk at least nineteen months after the protective inoculation 
(Schroeder and Cotton, and Weber and *11126). The trend of 
experimentation has naturally been toward the use of bacilli either 
deprived of reproductive power or modified by conditions of growth 
so as to lose parasitic features. The possibility of a strong relative 
immunity has been demonstrated, but much yet remains to be 
accomplished to make it. useful. 
To overcome the objections due to the use of living human 
bacilli in cattle, and to apply the principle of immunization to 
mankind, have been the problems of recent years. Hope of this 
achievement was held out by von Behring at the last International 
Congress at Paris in 1905. Nothing definite has been made public 
since to indicate that this hope was justified or that the immuniz¬ 
ing and therapeutic properties of the so-called “tulase” were 
superior to the bacillary preparation T.R. of Koch, introduced a 
decade before. > 
One fact has been prominent in the course of all investigations, 
and that is the superiority of living bacilli over all the preparations 
of dead bacilli for protective inoculation. The vital element has a 
more pronounced influence, even upon animals which completely 
resist infection by the immunizing vaccine and show no trace of the 
inoculated bacilli a short time afterward in their tissues. It is 
natural to suppose that the bacilli perish too quickly to adjust 
themselves to a parasitic existence by producing any hypothetical 
secretion, which might be the secret of their greater protective 
influence. It is admitted, however, that the degree of immunity is 
directly proportional to the virulence of the vaccine. The subtle 
difference between the immunizing value of living and of dead bacilli 
needs more investigation; likewise also the cause of variations in 
virulence. 
Repeated protective treatment must be considered necessary for 
success from the present outlook, and by means of an agent equally 
innocuous to cattle and mankind. It has been found that a period 
of two months after the first immunizing dose is required to develop 
the specific resistance in calves. Obviously, they must be protected 
from exposure to infection during this period. Probably the subse¬ 
quent protective treatments will more quickly become effective. 
It appears desirable to establish as strong local resistance as 
possible by subjecting all avenues of infection to local immuniza¬ 
tion; for example, by feeding and inhalation of the vaccine. 
In order to adjust the dosage and intervals the finer mechanism 
of immunity must be closely studied f The agglutinin and opsonin 
tests have not been satisfactory measures of resistance, and some 
way of estimating specific latent antituberculous cell energy is 
needed. When natural infection is taking place or the individual 
is undergoing immunization there are, it is true, evidences of 
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changes in the blood, but when no such stimulus is active the con¬ 
tent of antibodies—agglutinin, opsonin, or lysin—slowly drops to 
a normal level. There is then no sign of the latent specificity which 
we are as yet able to recognize, although a renewed infection or a 
tuberculin test may elicit it. 
Another phase of the problem is to establish a correct balance 
between the specific response to infection, which occurs during the 
hypersensitive stage of immunity and the ability of the tissue cells 
to assimilate the poisons without harm. 
An immunity that tends only to arrest the infection but not to 
overcome it, is not wholly beneficial when it creates ulceration at the 
portal of entrance of the bacillus (Th. Smith). Hence the question 
whether hypersensitiveness artificially induced by protective inocu¬ 
lations is beneficent or otherwise must be considered. It would 
seem vastly better, from what we know of the effects of hypersensi¬ 
tiveness in heightening the affinity of the body cells to a harmful 
degree for the poisons of tubercle bacilli, that it should be avoided. 
Specific bacteriolytic powers are useful in combatmg bacteria, but 
not in assimilating the dead and digested body substances of 
bacteria. 
Fortunately the number of bacilli to be disposed of at any given 
time is small under natural conditions of infection. It is conceivable 
that a relative tuberculosis immunity without tuberculin suscepti¬ 
bility being produced at some time during its development might be 
defective. On the other hand, complete tolerance to tuberculin in 
cattle may be associated with a high degree of resistance to infec¬ 
tion. 
The problem,.therefore, seems to be to create tolerance for the 
bacillus poisons and its products which have resulted from lysis, or 
to aid their safe assimilation by the tissues. 
Without the unknown quality called “tolerance” no real immunity 
can exist, and the earlier in life this can be established with absolute 
safety the more resistant the adult must become. That there is 
danger of harm in the process may easily be surmised from the 
grave impairment of nutrition resulting from experiments with dead 
bacilli, and the well-known anemia accompanying so-called latent 
tuberculosis. These difficulties I conceive to be the prominent ones, 
but they are here treated in a confessedly superficial manner. 
The studies of Bartel on the influence of lymphatic cells upon the 
tubercle bacillus, as well as those of Opie on the leukocytes, promise 
to enlarge our knowledge of this subject. Still more light may come 
from investigations now in progress on the mechanism of anaphy¬ 
laxis and its prevention. 
Finally the problem of passive immunity is still a distant goal 
which should not be forgotten. It must not be thought hopeless 
considering the progress of biologic research, though a serum therapy 
furnishes but a faint probability of success. Some other method of 
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directly neutralizing the cell poisons may yet be discovered with the 
increasing facilities generously being devoted to medical research. 
On this rests the hope of an efficient therapy to supplement all other 
means of prevention and cure. 
THE CAMMED GE REACTION IN EXPERIMENTAL 
PANCREATITIS.1 
By John Speese, M.D., and Edward H. Goodman, M.D., 
or FnnASELPBIA. 
{A preliminary report, from the William Pepper Clinical Laboratory of the University of 
Pennsylvania and the Private Laboratory of Dr. John H. Musser, Philadelphia.) 
It is rather surprising that, despite the great clinical value claimed 
for his test, Cammidge3 has so far made no attempt to control his 
observations by experimental work. Eichler3 studied the effect of 
experimental pancreatitis on the urine, producing in one dog hemor¬ 
rhagic pancreatitis, and in two dogs a diffuse purulent pancreatitis. 
The urines of these dogs before operation were negative, confirming 
the observation previously made that the urine of normal men, dogs, 
and rabbits does not give a positive pancreatic reaction. The post¬ 
operative examination of the urine, in each instance, was positive, 
which led Eichler to conclude that the test is of great value in diag¬ 
nosticating pancreatic disease. As he used the A and B reactions in 
his studies, and as these reactions have been severely criticised by 
Ham and Cleland,4 Scliroeder,5 Gruner,® Wilcox,7 and Haldane,® the 
the value of Eichler’s conclusions may be questioned. 
In 1907 Cammidge* described a third, or C reaction, which he 
claimed does away with many objections raised by bis critics. Very 
little clinical work has been done with the C test, apart from Cam- 
midge’s own researches, and, so far, no experimental work has been 
reported. The papers of Cammidge, Schroeder,10 and Goodman11 
have presented so much clinical evidence in favor of the reactions 
that we deemed it advisable to control these observations by experi¬ 
mentation. 
1 Read at a meeting of the College of Physicians of Philadelphia, December 2.1008. 
1 Robson and Cammidge, Hie Pancreas: Its Surgery and Pathology, 1008. 
* Berl. kiln. Woch., 1007, p. 769. 
< Australasian Medical Gazette, 1004, p. 309; Lancet, 1004,1,1378. ^ 1 Amer. Med., 1004, p. 406. 1 • Lanoet, 1904, i, 1469. 
T Lancet, 1904, il, 21L « Edin. Med. Jour., 1906,Jxx, 418. 
• Loc. dt.. p. 252. 
10 Jour. Amer. Med. Assoc., 1908, li, 837. 
" Read by invitation at a meeting of tho Philadelphia Academy of Surgery. November 2, 
1908, and to be published in the Annals of Surgery, February, 1909. 
